GlassScriptPhysician profile
Mitchell K Schwaber
NPI 1629050372
$769.37
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $87.11 · 2021: $122 · 2022: $250 · 2023: $47.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $163.34 | 2019-2022 | |
| Intersect Ent, INC. | $104.91 | 2019-2021 | |
| Acclarent, INC | $103.70 | 2022-2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $88.96 | 2022 | |
| Advanced Bionics, LLC | $59.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $58.39 | 2019 | |
| Integra Lifesciences Corporation | $36.75 | 2019 | |
| Alk-Abello, INC | $34.70 | 2019-2021 | |
| Medtronic, INC. | $22.80 | 2022 | |
| Oticon Medical, LLC | $22.65 | 2021 | |
| Genzyme Corporation | $21.26 | 2022 | |
| Kerecis Limited | $19.89 | 2022 | |
| Cochlear Americas | $18.08 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Schwaber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.